• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits

cafead

Administrator
Staff member
  • cafead   Nov 26, 2022 at 07:12: PM
via Teva Pharmaceutical and AbbVie’s Allergan are finally on the verge of putting thousands of opioid lawsuits to bed.


The companies this week locked in a combined $6.6 billion in settlements to resolve allegations that they helped fuel the U.S. opioid epidemic by overstating the painkillers’ benefits, downplaying the risk of addiction and failing to maintain controls to prevent opioid misuse.

article source
 

<